In the present study, the expression and prognostic role of the CD44 splicing variants v5 and v6 were immunohistochemically investigated in 418 curatively resected gastric carcinomas. CD44v5 was expressed in 65β’3 per cent (n=273) and CD44v6 in 77β’0 per cent (n=322) of the tumours. Whereas the expres
CD44 and its v6 spliced variant in lung tumors : A role in histogenesis?
β Scribed by Maria Fasano; Maria T. Sabatini; Rosemary Wieczorek; Gurdip Sidhu; Sunanda Goswami; Jaishree Jagirdar
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 404 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
The authors investigated the expression of CD44s and its v6 isoform Jaishree Jagirdar, M.D. 4 (CD44v6) immunohistochemically in 7 fetal lungs (gestational age between 11-36 weeks) and in 80 lung tumors of various histologic types, degrees of differentiation,
π SIMILAR VOLUMES
The expression of the standard CD44 (CD44s) and its v6 isoform (CD44v6) was analysed immunohistochemically in 173 cases of transitional cell bladder cancer. The results of immunohistochemical analyses were related to established prognostic factors and clinical follow-up data. The expression intensit